pharmaceuticals-and-healthcare

Global Cytotoxic Drug Market Research Report Forecast 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 156 pages

  • $2900
  • $5800

Please click below to avail discount on this report

This report studies the Cytotoxic Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Cytotoxic Drug market by product type and applications/end industries.



In the last several years, global market of Cytotoxic Drug developed slowly, with an average growth rate of 0.75%. In 2016, global revenue of Cytotoxic Drug is nearly 13.5 Billion M USD.



The major players in global Cytotoxic Drug market include

Roche

Eli Lilly

Celgene

Sanofi

eisai

Sumitomo Dainippon Pharma

Merck

Seattle Genetics

Takeda

Haosoh Pharma

Novartis

AstraZeneca

Jazz Pharma

Spectrum Pharma



Geographically, this report is segmented into several key Regions consumption, revenue, market share and growth rate of Cytotoxic Drug in these regions, from 2012 to 2022 (forecast), covering

USA

Europe

Japan

China

RoW



On the basis of product, the Cytotoxic Drug market is primarily split into

Injection

Solid Oral Dose Forms

Others



On the basis on the end users/applications, this report covers

Breast Cancer

Blood Cancer

Prostate Cancer

Respiratory/Lung Cancer

Other







In the recent times, the global market for Global cytotoxic drug market research report forecast 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global cytotoxic drug market research report forecast 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global cytotoxic drug market research report forecast 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global cytotoxic drug market research report forecast 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global cytotoxic drug market research report forecast 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global cytotoxic drug market research report forecast 2017, including the definition, classification, and industry chain structure of Global cytotoxic drug market research report forecast 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global cytotoxic drug market research report forecast 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global cytotoxic drug market research report forecast 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global cytotoxic drug market research report forecast 2017, implemented in each of the geographical segments. The predominant applications of the Global cytotoxic drug market research report forecast 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global cytotoxic drug market research report forecast 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global cytotoxic drug market research report forecast 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Cytotoxic Drug1
Table Classification of Cytotoxic Drug2
Figure Global Cytotoxic Drug Production Market Share by Types in 20162
Figure Injection Example3
Figure Solid Oral Dose Forms4
Table Application of Cytotoxic Drug4
Figure Global Cytotoxic Drug Consumption Market Share by Applications in 20165
Figure Blood Cancer Examples6
Figure Breast Cancer Examples6
Figure Prostate Cancer Examples7
Figure Respiratory/Lung Cancer Examples8
Figure Global Cytotoxic Drug Market Size (M USD) Comparison by Regions (2012-2022)9
Figure USA Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2022)10
Figure China Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2022)11
Figure Europe Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2022)12
Figure Japan Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2022)13
Figure Global Cytotoxic Drug Revenue (M USD) Status and Outlook (2012-2022)14
Table Global Cytotoxic Drug Revenue (M USD) of Key Manufacturers (2016-2017)15
Table Global Cytotoxic Drug Revenue Market Share by Manufacturers (2012-2017)15
Figure 2016 Cytotoxic Drug Revenue Market Share by Manufacturers16
Figure 2017 Cytotoxic Drug Revenue Market Share by Manufacturers17
Table Global Cytotoxic Drug Gross (M USD) by Manufacturers (2016-2017)17
Table Global Cytotoxic Drug Gross Share by Manufacturers (2016-2017)18
Figure 2016 Global Cytotoxic Drug Gross Share by Manufacturers19
Figure 2017 Global Cytotoxic Drug Gross Share by Manufacturers20
Table Global Market Cytotoxic Drug Average Gross Margin of Key Manufacturers (2016-2017)20
Figure Global Market Cytotoxic Drug Average Gross Margin of Key Manufacturers in 201621
Figure Global Market Cytotoxic Drug Average Gross Margin of Key Manufacturers in 201722
Table Manufacturers Cytotoxic Drug Headquarters and Established Date22
Table Manufacturers Cytotoxic Drug Product Type23
Table Global Cytotoxic Drug Revenue Market Share by Manufacturers (2016-2017)24
Figure Cytotoxic Drug Revenue Market Share of Top 3 Manufacturers in 201625
Figure Cytotoxic Drug Market Share of Top 5 Manufacturers in 201625
Table Mergers & Acquisitions, Expansion26
Table Global Cytotoxic Drug Revenue (M USD) by Regions (2012-2017)28
Table Global Cytotoxic Drug Revenue Market Share by Regions (2012-2017)28
Figure Global Cytotoxic Drug Revenue Market Share by Regions (2012-2017)29
Figure 2016 Global Cytotoxic Drug Revenue Market Share by Regions29
Table Global Cytotoxic Drug Gross (M USD) by Regions (2012-2017)30
Figure Global Cytotoxic Drug Revenue Market Share by Regions (2012-2017)30
Figure 2016 Global Cytotoxic Drug Revenue Market Share by Regions31
Figure Global Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2017)31
Table Global Cytotoxic Drug Revenue (M USD), Gross (M USD), Cost (M USD) and Gross Margin (2012-2017)32
Figure USA Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2017)32
Table USA Cytotoxic Drug Revenue (M USD), Gross (M USD), Cost (M USD) and Gross Margin (2012-2017)33
Figure Europe Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2017)33
Table Europe Cytotoxic Drug Revenue (M USD), Gross (M USD), Cost (M USD) and Gross Margin (2012-2017)34
Figure China Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2017)34
Table China Cytotoxic Drug Revenue (M USD), Gross (M USD), Cost (M USD) and Gross Margin (2012-2017)35
Figure Japan Cytotoxic Drug Revenue (M USD) and Growth Rate (2012-2017)35
Table Japan Cytotoxic Drug Revenue (M USD), Gross (M USD), Cost (M USD) and Gross Margin (2012-2017)36
Table Global Cytotoxic Drug Consumption (M USD) Market by Regions (2012-2017)37
Table Global Cytotoxic Drug Consumption Market Share by Regions (2012-2017)37
Figure Global Cytotoxic Drug Consumption Market Share by Regions (2012-2017)38
Figure 2016 Global Cytotoxic Drug Consumption Market Share by Regions38
Figure North America Cytotoxic Drug Consumption (M USD) and Growth Rate (2012-2017)39
Figure Europe Cytotoxic Drug Consumption (M USD) and Growth Rate (2012-2017)40
Figure Asia-Pacific Cytotoxic Drug Consumption (M USD) and Growth Rate (2012-2017)41
Figure South America Cytotoxic Drug Consumption (M USD) and Growth Rate (2012-2017)42
Figure Middle East and Africa Cytotoxic Drug Consumption (M USD) and Growth Rate (2012-2017)43
Table Global Cytotoxic Drug Revenue (M USD) by Types (2012-2017)44
Table Global Cytotoxic Drug Revenue Market Share by Types (2012-2017)44
Figure Revenue Market Share of Cytotoxic Drug by Types (2012-2017)45
Figure 2016 Revenue Market Share of Cytotoxic Drug by Types45
Figure Global Cytotoxic Drug Revenue Growth Rate by Types (2012-2017)46
Table Global Cytotoxic Drug Consumption (M USD) by Applications (2012-2017)47
Table Global Cytotoxic Drug Consumption Market Share by Applications (2012-2017)47
Figure Global Cytotoxic Drug Consumption Market Share by Applications (2012-2017)48
Figure Global Cytotoxic Drug Consumption Market Share by Applications in 201648
Table Global Cytotoxic Drug Consumption Growth Rate by Applications (2012-2017)49
Figure Global Cytotoxic Drug Consumption Growth Rate by Applications (2012-2017)49
Table Roche Company Profile51
Figure Cytotoxic Drug Product Picture of Roche52
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2016-201753
Table Eli Lilly Company Profile53
Figure Cytotoxic Drug Product Picture of Eli Lilly54
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2016-201755
Table Celgene Company Profile56
Figure Cytotoxic Drug Product Picture of Celgene57
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Celgene 2016-201757
Table Sanofi Company Profile58
Figure Cytotoxic Drug Product Picture of Sanofi59
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Sanofi 2016-201761
Table Eisai Company Profile61
Figure Cytotoxic Drug Product Picture of Eisai62
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eisai 2016-201762
Table Sumitomo Dainippon Pharma Company Profile63
Figure Cytotoxic Drug Product Picture of Sumitomo Dainippon Pharma64
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Sumitomo Dainippon Pharma 2016-201764
Table Merck Company Profile64
Figure Cytotoxic Drug Product Picture of Merck66
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck 2016-201766
Table Seattle Genetics Company Profile67
Figure Cytotoxic Drug Product Picture of Seattle Genetics69
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Seattle Genetics 2016-201769
Table Takeda Company Profile70
Figure Cytotoxic Drug Product Picture of Takeda71
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2016-201771
Table Haosoh Pharma Company Profile72
Figure Cytotoxic Drug Product Picture of Haosoh Pharma73
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Haosoh Pharma 2016-201773
Table Novartis Company Profile74
Figure Cytotoxic Drug Product Picture of Novartis75
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Novartis 2016-201775
Table AstraZeneca Company Profile76
Figure Cytotoxic Drug Product Picture of AstraZeneca77
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of AstraZeneca 2016-201777
Table Jazz Pharma Company Profile77
Figure Cytotoxic Drug Product Picture of Jazz Pharma79
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Jazz Pharma 2016-201779
Table Spectrum Pharma Company Profile80
Figure Cytotoxic Drug Product Picture of Spectrum Pharma81
Table Cytotoxic Drug Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Spectrum Pharma 2016-201782
Figure Typical Phases from Research to the Market for a Drug Candidate84
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound85
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound86
Figure Manufacturing Cost Structure of Cytotoxic Drug86
Figure USA Labor Cost Analysis 2012-201687
Figure Cost of Employing a Factory Worker88
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe89
Figure Monthly Minimum Wages in Asia 201690
Figure China Labor Costs 2013-201690
Table Average Price of Electricity to Ultimate Customers 2007-201691
Figure Electricity Prices for Household Consumers in 201692
Figure Summary of the Driving Assumptions94
Figure Industrial Electric Rates 2016 (PER KWH)94
Figure Manufacturing Process Analysis of Cytotoxic Drug96
Figure Cytotoxic Drug Industrial Chain Analysis97
Table Major Buyers of Cytotoxic Drug98
Figure Setting Pricing Policy103
Table Distributors/Traders List105
Figure New Active Substance Launches 2011-2015 by Indication106
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.107
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015108
Figure Key In-Market and Investigational Agents for NSCLC109
Figure Key In-Market and Investigational Agents for Melanoma109
Figure the Global Late Phase Oncology Pipeline in 2015110
Figure Companies with Active Late Phase Oncology Pipelines111
Figure Global GDP Growth Rate for 2016112
Figure US GDP 2006-2016 (Billion USD)113
Figure US CPI Change 2016-2017113
Figure EU GDP 2006-2016 (Billion USD)114
Figure EU CPI Change 2012-2016114
Figure Germany GDP 2006-2016 (Billion USD)115
Figure Germany CPI Change 2016-2017115
Figure UK GDP 2006-2016 (Billion USD)115
Figure UK CPI Change 2016-2017116
Figure Italy GDP 2006-2016 (Billion USD)116
Figure Italy CPI Change 2016-2017117
Figure Japan GDP 2006-2016 (Billion USD)117
Figure Japan CPI Change 2012-2016118
Figure China GDP 2006-2016 (Billion USD)118
Figure China CPI Change 2016-2017119
Figure Global Cytotoxic Drug Revenue (M USD) and Growth Rate Forecast (2017-2022)120
Figure USA Cytotoxic Drug Revenue (M USD) and Growth Rate Forecast (2017-2022)121
Figure Europe Cytotoxic Drug Revenue (M USD) and Growth Rate Forecast (2017-2022)122
Figure Japan Cytotoxic Drug Revenue (M USD) and Growth Rate Forecast (2017-2022)123
Figure China Cytotoxic Drug Revenue (M USD) and Growth Rate Forecast (2017-2022)124
Table Global Cytotoxic Drug Consumption (M USD) Forecast by Regions (2017-2022)124
Table Global Cytotoxic Drug Consumption Market Share Forecast by Regions (2017-2022)125
Figure Global Cytotoxic Drug Consumption Market Share Forecast by Regions (2017-2022)125
Figure Global Cytotoxic Drug Consumption Market Share Forecast by Regions in 2022126
Figure North America Cytotoxic Drug Consumption (M USD) and Growth Rate Forecast (2017-2022)127
Figure Europe Cytotoxic Drug Consumption (M USD) and Growth Rate Forecast (2017-2022)128
Figure Asia-Pacific Cytotoxic Drug Consumption (M USD) and Growth Rate Forecast (2017-2022)129
Figure South America Cytotoxic Drug Consumption (M USD) and Growth Rate Forecast (2017-2022)130
Figure Middle East and Africa Cytotoxic Drug Consumption (M USD) and Growth Rate Forecast (2017-2022)131
Table Global Cytotoxic Drug Revenue (M USD) Forecast by Types (2017-2022)131
Table Global Cytotoxic Drug Revenue Market Share Forecast by Types (2017-2022)132
Figure Global Cytotoxic Drug Revenue Market Share Forecast by Types (2017-2022)132
Figure Global Cytotoxic Drug Revenue Market Share Forecast by Types in 2022133
Table Global Cytotoxic Drug Consumption (M USD) Forecast by Application (2017-2022)133
Table Global Cytotoxic Drug Consumption Market Share Forecast by Application (2017-2022)133
Figure Global Cytotoxic Drug Consumption Forecast by Application (2017-2022)134
Figure Global Cytotoxic Drug Consumption Forecast by Application in 2022135
Table Research Programs/Design for This Report137
Figure Bottom-up and Top-down Approaches for This Report139
Figure Data Triangulation140
Table Key Data Information from Secondary Sources141
Table Key Data Information from Primary Sources142

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top